Episode 443: ESMO 2025 Bladder Cancer Pr...

<p>Michael Morris from MSKCC joins us for an in-depth review of ARPI development across the spectrum of prostate caner</p> 

Brian and Tom tag team moderate this session which covers combination data, VEGF/PD1 bispecifics, microbiome approaches, cellular therapy and enrichment strategies. 

Tom leads the panel discussion about this evolving space including the RAMPART data and the press release about pembro/belzu. 

<p>Today’s episode is focusing on bladder cancer - what you need to know about the pathology, presentation, diagnostic work-up, staging, treatment, and rarer upper GU tract presentations.</p> 

<p>We are doing a special episode this week to cover some of the key GU abstracts from ESMO 2024. We cover an update on the STAMPEDE prostate cancer trial, SUNNIFORECAST in non-clear cell renal cell carcinoma, SunRISe-4 in bladder cancer, and more.</p> 

Hot off the press: The BOSS (Barrett’s Oesophagus Surveillance Versus Endoscopy at Need Study) randomised control study. Is surveillance really not affecting survival in oesophageal cancer patients? To put things into perspective, we asked Massimiliano Di Pietro, UEG Talks podcas ... Show More

<p>This is the first of a two part episode on prostate cancer. This episode will cover localized prostate cancer, including the diagnostic work-up, staging and treatment. </p> 

<p>In this podcast, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) interviews Dr. Srikala Sridhar (CA), about her abstract she recently presented at ESMO 2023, PET-MUSE: “Impact of positron emission tomography (PET) imaging on staging of muscle-invasive bladder cancer (MIBC)” ... Show More

About 1 in 8 men will be diagnosed with prostate cancer during their lifetime. Join Lauren Bright Pacheco at the 2024 ASCO Annual Meeting in Chicago, as she investigates the advancements in prostate cancer care.  Dr. Mohammad Atiq shares ways innovative treatments are paving the ... Show More

Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More

<p>This week’s episode will be focusing on Esophageal and Gastrosophageal Junction (GEJ) Cancer. We will go over important details on the risk factors, diagnosis, and treatment for both localized and metastatic esophageal cancer.</p><p><br/></p> 

Our guest is Dr. Kyle Richards, a urologic oncologist and Associate Professor in the Department of Urology at the University of Wisconsin. He talks with us about the basics around non-muscle invasive bladder cancer. Learn about common symptoms, diagnosis and treatment options to ... Show More

<p>Ninja Nerds!</p><p>In this episode of the Ninja Nerd Podcast, Zach and Rob break down the essential clinical and pathophysiologic features of <b>Prostate Cancer</b>, one of the most common malignancies affecting men worldwide.</p><p>We begin with the <b>epidemiology and risk f ... Show More